ABOUT US

Innovating at the speed of AI

The world has undergone a rapid and transformative shift since the adoption of AI. This is particularly evident in biopharma, where the possibility of a truly ground-breaking solution that accelerates research, disease diagnosis and trial-matching is at hand.

We’ve assembled an exceptional team to do just that, comprised of individuals with an indisputable track record of excellence.

Meet the team

Ryght | Simon Arkell

Simon Arkell

Co-Founder & CEO
Simon is a hi tech entrepreneur and investor with a focus on AI and healthcare technology. Co-founder of 7 venture backed companies, including Deep Lens, Predixion Software and Versifi, which together raised over $100M in venture backing. All three were acquired.
Ryght | Alex Dickinson

Alex Dickinson

Co-Founder & Chairman
Co-founder/Chair/CEO: ChromaCode (COVID XPrize winner); Helixis (acquired by Illumina) and Luxtera (acquired by Cisco). Board member Gencove (low pass sequencing) and previously PRA Health Sciences (public, acquired by ICON). Seven year Illumina SVP (led BaseSpace and PopSeq businesses). Began career in research at Bell Labs; co-inventor of the CMOS fingerprint sensor.
Ryght | Chadi Nabhan

Chadi Nabhan

Chief Medical Officer & Head of Strategy

Dr. Chadi Nabhan is the Chief Medical Officer and Head of Strategy at Ryght, bringing over 20 years of oncology and leadership experience to drive innovation and strategic vision.

His past roles include SVP and Chairman of the POA at Caris Life Sciences, VP and CMO at Cardinal Health Specialty Solutions, and EVP and CMO at Aptitude Health. Academically, he has served as an Associate Professor of Medicine and the Director of Outpatient Cancer Clinics at the University of Chicago, and before that, Chief of Oncology and Cancer Institute Medical Director at Advocate Lutheran General Hospital in Park Ridge, IL. Dr. Nabhan is an esteemed author, podcaster, and speaker, recognized for his contributions to medical oncology and clinical research. 

Ryght | Sara Dada

Sara Dada

Senior Director of Product
Sara Dada is an experienced Product Management professional based in the San Francisco Bay Area. She has previously served on the product team of a B2B SaaS company, consulted for various startups, and worked as a data analyst for a venture fund. She studied Business Administration and Technology Ethics at Cal Poly SLO.
Ryght | Isabella Murrell

Isabella Murrell

Senior Director of AI & Engineering
Isabella Murrell, Senior Director of AI and Engineering at Ryght, leads our international engineering team in building innovative health-tech solutions. With a foundation in biomedical engineering and machine learning, she bridges complex technical challenges to real-world patient impact while championing a people-first, collaborative culture.
Ryght | Dylan Wallace

Dylan Wallace

Director of Business Development
As Director of Business Development, Dylan leads Ryght’s efforts to build relationships with customers and generate new business. Coming from the CRO space, at IQVIA Biotech, he understands the needs of biotech clients as well as the nuances of the clinical trial landscape. Dylan studied Business Administration and International Affairs at the University of North Carolina Wilmington and still calls Wilmington his home. When he is not working, you can find him at the pickleball courts, on the golf course, traveling the world, or spending time with his family.
Ryght | Ariel Paradis

Ariel Paradis

Director of Marketing
As Director of Marketing, Ariel leads brand and product marketing at Ryght, drawing on over ten years of experience in B2B healthcare and technology industries. She is dedicated to building impactful brands and go-to-market strategies that ultimately drive innovation in the clinical research space.
Ryght | Elizabeth Keller

Elizabeth Keller

Customer Success Lead
Elizabeth brings a strong foundation in healthcare operations and client coordination to her role as Customer Success Lead at Ryght AI. With experience managing complex clinical trials at Georgetown Lombardi Comprehensive Cancer Center and University of Pennsylvania, she excels at building relationships and ensuring exceptional client outcomes. Having worked closely with patients and healthcare professionals, Elizabeth is passionate about supporting those who make a difference in healthcare and believes meaningful connections drive successful partnerships. She's passionate about leveraging technology to drive efficiency and help clients achieve their goals—and support them every step of the way.
Ryght | Sharath Mahadevan

Sharath Mahadevan

Customer Solutions Engineer

Sharath is a Customer Engineer specializing in AI-powered solutions for clinical trials, bringing a strong foundation in computer science with concentrated expertise in Artificial Intelligence. He combines technical proficiency in software development with a deep understanding of healthcare innovation, positioning him at the forefront of transforming clinical research through advanced AI technologies.

In his role at Ryght, Sharath leverages his comprehensive knowledge of AI systems and healthcare workflows to drive meaningful improvements in clinical trial processes. His unique blend of technical expertise and passion for healthcare advancement enables him to bridge the gap between cutting-edge AI capabilities and real-world clinical applications, contributing to revolutionary changes in how clinical trials are conducted and managed.

Ryght | Tarek Sherif

Tarek Sherif

Advisor

Tarek Sherif, former CEO and co-founder, Medidata Solutions & Ryght Advisor, co-founded Medidata Solutions in 1999, where he played a pivotal role in transforming clinical research by automating and digitizing trials through cloud-based solutions. Under his leadership, Medidata became the industry standard for clinical trial data management and analytics, by delivering leading edge technology along with customer centric services.  

Sherif brings a wealth of experience and a proven track record in pioneering cloud-based solutions and automating clinical trials.

Investors

Ryght's initial funding is supported by leading investors with a shared vision to improve healthcare by leveraging advances in AI technology. The initial round was led by Virtue with participation from AIX Ventures, Iaso Ventures, Page One Ventures, Top Harvest Capital, and additional strategic angel investors.

Partners

We understand that the foundation of transformative life sciences solutions rests on cutting-edge technology, robust security, and infinite scalability. To ensure our customers experience unparalleled success, we strategically partner with the industry’s leading technology and cloud service providers. Our meticulously selected network of partners empowers us to deliver secure, scalable, and cutting-edge AI-driven solutions tailored for the unique challenges of the life sciences sector. 

KEEP UP WITH RYGHT

Stay Connected

Subscribe to be the first to know about product updates, news and announcements.